Revance Therapeutics | Aktiva

Assets Perubahan Tanggal
AbbVie USD 136.22B 854M 2023-09
ALKERMES USD 2.28B 92.05M 2023-09
Bristol-Myers Squibb USD 91.26B 2.23B 2023-09
Eli Lilly USD 57.92B 3.1B 2023-09
Merck USD 106.73B 2.26B 2023-09
Neurocrine Biosciences USD 2.85B 235.1M 2023-09
Pacira USD 1.57B 39.92M 2023-12
Supernus Pharmaceuticals USD 1.28B 7.49M 2023-12



Revance Therapeutics Aktiva - Nilai saat ini, data historis, perkiraan, statistik, grafik dan kalender ekonomi - Apr 2024.